HomeInvestors HealthEli Lilly, Novo stocks in focus as RFK Jr. leads HHS (NVO:NYSE) Eli Lilly, Novo stocks in focus as RFK Jr. leads HHS (NVO:NYSE) By BOMAR ENT. February 16, 2025 FacebookTwitterPinterestWhatsApp Andrew Harnik/Getty Images News Obesity drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) have found themselves in two contrasting positions as Robert F. Kennedy Jr., a leading critic of weight loss drugs, takes the helm of the Department of Health Source link Previous articleAre Our Predictions Already Wrong?Next articleTHE PATH TO SUCCESS IN TRADING latest articles explore more Zscaler: Sales Machine Is Operating Well Again, After A Clunky 2024 High Returns from Low Risk: A Remarkable Stock Market Paradox Day Trading 101: How To Day Trade Stocks For Passive Income: Learn The Basics Of Stock Market Day Trading: Chart Setting, Technical Patterns, Indicators,... Bank of China reports FY results AI for Good: Applications in Sustainability, Humanitarian Action, and Health Revocable Living Trusts: The Good, the Bad and the Ugly LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
